CG
IRWD icon

Colony Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Colony Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-258,160
Closed -$2.32M – 747
2020
Q3 		$2.32M Hold
258,160
– – 0.06% 249
2020
Q2 		$2.66M Hold
258,160
– – 0.08% 220
2020
Q1 		$2.6M Sell
258,160
-256,852
-50% -$3.02M 0.08% 208
2019
Q4 		$6.86M Hold
515,012
– – 0.17% 141
2019
Q3 		$4.42M Buy
+515,012
New +$5M 0.14% 168

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Colony Group's IRWD Position: Q4 2020 in Review

Colony Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2020, closing a stake of 258,160 shares — an estimated $2.32M sold.

Colony Group first reported a position in IRWD in Q3 2019 and held it in 5 quarters. The position peaked at $6.86M in Q4 2019. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

  • Colony Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Colony Group sold 258,160 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $2.32M.
  • Colony Group first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 5 quarters.
  • Colony Group's Ironwood Pharmaceuticals position peaked at $6.86M in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on Colony Group's 13F filing for Q4 2020, filed 16 Feb 2021.